Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Breast Cancer Res Treat. 2009 Dec 22;122(1):229–235. doi: 10.1007/s10549-009-0681-x

Table 2.

Hazard ratios and 95% confidence intervals (CI) for the association between dietary lignan intake and death from all causes or breast cancer in the Western New York Exposures and Breast Cancer Study

Lignan intake (mcg/d) Events (n) Hazard ratio (95% CI)
Premenopausal (n = 315)
All cause mortality
 < 128 7 1.00
 128–181 12 1.54 (0.59–3.98)
 181–257 7 0.88 (0.30–2.58)
 >257 18 2.14 (0.82–5.56)
P for trend 0.02
Breast cancer mortality
 < 128 6 1.00
 128–181 12 1.70 (0.62–4.62)
 181–257 6 0.83 (0.26–2.67)
 >257 14 1.84 (0.65–5.27)
P for trend 0.03
Postmenopausal (n = 807)
All cause mortality
 < 155 33 1.00
 155–227 33 0.91 (0.55–1.52)
 227–318 29 0.78 (0.46–1.33)
 >318 21 0.49 (0.26–0.91)
P for trend 0.02
Breast cancer mortality
 < 155 18 1.00
 155–227 20 0.94 (0.48–1.87)
 227–318 11 0.51 (0.23–1.15)
 >318 7 0.29 (0.11–0.76)
P for trend 0.01

Cox proportional hazards adjusting for age, race, total energy, stage at diagnosis, body mass index, and education